The Psychedelics as Medicine Report: Third Edition

November 29, 2022
September 30, 2021

Read the report on Psych Global

‍

Related posts
May 4, 2023
First patient dosed in Beckley Psytech’s Phase IIa study of BPL-003 for Treatment Resistant Depression
April 24, 2023
Beckley Psytech to present data from Phase I study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin), at upcoming scientific conference
April 5, 2023
Beckley Psytech initiates Phase IIa study of 5-MeO-DMT candidate BPL-003 for Alcohol Use Disorder